Back to VANGUARD GROUP INC VANGUARD GROUP INC

LEXXLEXX
6 quarters

Position history for VANGUARD GROUP INCVANGUARD GROUP INC's holdings in LEXARIA BIOSCIENCE CORP

As of its last 13F, for Q4 2025, Vanguard Group held 258,816 shares of LEXX (Lexaria Bioscience), worth $159,689. The share count is unchanged from Q3 2025. Vanguard Group held LEXX from Q3 2024 to Q4 2025, across 6 quarterly 13F filings.

Current Value

$159,689

Current Shares

258,816

Total Value Change

-$172,828

Total Shares Change

+149,794

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Unchanged
258,816
0.0%
$159,6890.0%$9.26
0
2025-Q3
Increased
258,816
+93.8%
$246,6510.0%$14.30
25
2025-Q2
Increased
133,554
+4.4%
$116,1920.0%$13.05
16
2025-Q1
Increased
127,871
+0.3%
$218,6600.0%$25.65
16
2024-Q4
Increased
127,433
+16.9%
$267,6090.0%$31.50
18
2024-Q3
First report
109,022
-
$332,5170.0%$45.75
0

Other major holders of LEXX: GEODE CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used